AstraZeneca stock dives 9% after heart drug trial misses target
Shares of AstraZeneca fell as much as 9% after a late-stage clinical trial for a heart disease failed…
A new wave of weight-loss therapies aims to be better than today’s GLP-1s
Last Updated: June 7, 2026 at 10:18 a.m. ETFirst Published: June 6, 2026 at 2:53 p.m. ET One of the…
AstraZeneca CEO says AI is reshaping drug development — and helping boost the odds of success
AstraZeneca CEO Pascal Soriot said artificial intelligence is helping drugmakers develop medicines faster and make smarter decisions throughout…
Reality of Trump’s drug pricing to set in over next 18 months
Vas Narasimhan, chief executive officer of Novartis AG, during an announcement in the Roosevelt Room of the White…
More drugs should be over-the-counter
Food and Drug Administration Commissioner Marty Makary told CNBC that he believes “everything should be over the counter”…
UK, China rush to forge business deals
China’s President Xi Jinping (R) and Britain’s Prime Minister Keir Starmer shake hands before their meeting at the…
Roche’s Potential Blockbuster Fuels Best Month Since 1997
Roche Holding AG’s shares just posted their best month since 1997, lifted by optimism over an experimental breast…